Why the DSM Cannot See Them

In the previous essay in this series, I argued that mainstream psychiatry is not a broken system but an incomplete one. Built around a specific set of biological assumptions, tested on a narrow population, and calibrated to a particular picture of what mental illness looks like and where it comes from, it serves some people well and misses others in ways that compound over years and decades.

This essay is about who gets missed, and why the instrument the system uses to see cannot find them.

The instrument is the Diagnostic and Statistical Manual of Mental Disorders, now in its fifth edition. The DSM is the foundational text of American psychiatric diagnosis. It defines every condition a clinician can bill for, every symptom cluster that opens a door to treatment, and every category that determines what kind of care a person receives. Understanding its architecture is essential to understanding its limits.

A DSM diagnosis works by pattern recognition. A patient reports a set of symptoms. The clinician checks whether those symptoms, appearing together, for a sufficient duration, and at a sufficient level of severity, match a defined category. If they do, a diagnosis is made. The diagnosis says that this pattern of symptoms constitutes this condition.

What a diagnosis does not say, and structurally cannot say, is why those symptoms are there. It describes a presentation; it does not explain an origin. For a significant portion of the people who walk into a psychiatric clinic, that gap between description and explanation is where the real problem lives, unnamed and untreated.

The DSM-5 field trials, published in the American Journal of Psychiatry in 2013, found inter-rater reliability kappas for major depressive disorder of approximately 0.28, and for generalized anxiety disorder of approximately 0.20. These figures mean that two clinicians evaluating the same patient, using the same manual, agreed on the diagnosis less than a third of the time. This is the system's own published data. The instrument that determines what care millions of people receive is, by its own measure, producing inconsistent results. For the populations described below, the reasons for that inconsistency are not random. They are structural.

The Diagnostic Instrument and Its Built-In Blind Spots

Before describing who gets missed, it is worth being precise about why the DSM misses them.

The DSM is a symptom-based system. It was not designed to assess traits, adaptive strategies, developmental histories, or the relationship between a person's nervous system and the environment that shaped it. It was designed to categorize observable and reported symptoms into treatable conditions. That design serves certain patients well. For others, it means the most important clinical information is invisible to the instrument being used to see them.

The DSM also reflects the population on which it was built. The research underlying its diagnostic categories was conducted predominantly on white, Western, and often male samples drawn from academic medical centers. The symptom presentations coded into the manual, the thresholds for what counts as clinically significant, and the norms against which deviation is measured were all calibrated on a slice of humanity that was never representative of the full range of human experience or expression. Applied universally, it measures deviation from a norm that was never universal to begin with.

This is not an incidental flaw. It is a foundational one, and its consequences are most visible in the five populations below.

1. Highly Sensitive People

Elaine Aron's research, first published in 1997 and replicated across dozens of subsequent studies, identified high sensitivity as a measurable neurobiological trait present in approximately 15 to 20 percent of the population. Highly sensitive people process sensory and emotional information more deeply than average. They are more easily overwhelmed by intense stimulation, and they respond more strongly to subtleties in their environment. Their nervous systems are wired for depth, intensity, and permeability in ways that are consistent, heritable, and well-documented in the empirical literature.

The DSM has no category for this trait. It was not built to recognize that a nervous system can be constitutionally different without being disordered.

What happens when a highly sensitive person enters a psychiatric clinic? Their nervous system is doing exactly what a highly sensitive nervous system does in a world that was not designed for it. The chronic overstimulation produces anxiety. The emotional intensity, uncontained by a culture that has no framework for it, produces dysregulation that looks like a mood disorder. The exhaustion of moving through environments calibrated for a less permeable nervous system produces what looks like depression. The clinician sees the symptoms, the DSM provides the categories, and the diagnosis is made.

The diagnosis is not wrong, exactly. The anxiety and depression are real, but they are downstream. They describe what happened to a particular kind of nervous system in a particular kind of world. Treating the anxiety without recognizing the trait is like treating a fever without asking what caused the infection.

The highly sensitive person leaves with a diagnosis that tells them something is wrong with them. What they needed to hear is that something is different about them, and that difference has a name, a biological basis, and specific implications for how they need to live. That information is not available within a DSM-based framework because the DSM cannot see traits. It can only see symptoms.

2. Neurodivergent Adults

Adults with ADHD, autism, or both who have spent their lives masking present a specific and well-documented diagnostic challenge. Masking, which is the effortful suppression of neurodivergent traits to perform neurotypical behavior, is a survival strategy that develops early, often unconsciously, and at significant neurological cost. By the time a masking neurodivergent adult reaches a psychiatric clinic, they have typically accumulated years of anxiety, depression, and sometimes addiction. Those conditions are real. They are also, in large part, the result of the masking itself rather than independent disorders.

The DSM diagnostic process relies on observed and reported behavior. Successful masking suppresses the behaviors the DSM criteria are looking for. A masked ADHD adult presents as anxious and exhausted, not as the hyperactive child the diagnostic criteria were built around. A masked autistic adult presents as socially competent but internally depleted, not as the young boy in a 1980s textbook who avoids eye contact and has narrow, repetitive interests. The underlying neurotype goes unidentified because it has been rendered invisible by design.

This misidentification is not evenly distributed. ADHD and autism in girls, women, and people of color are dramatically underdiagnosed. The diagnostic criteria for both conditions were developed almost entirely on white male samples. The presentations common in girls and women, such as social masking, internalized rather than externalized symptoms, and anxiety or people-pleasing as the primary face of ADHD, were not part of the original picture the manual was built to recognize.

A Black girl masking in a classroom does not typically get referred for assessment. She gets labeled a behavioral problem or overlooked entirely. The cost of masking accumulates unnamed across years of education and development until she arrives in a clinic in her thirties with anxiety, depression, and a sense that something has always been fundamentally wrong with her. The DSM can diagnose the anxiety and depression, but it was not built to see what produced them. Treating anxiety and depression in a neurodivergent adult without identifying the underlying neurotype is treating the smoke without looking for the fire. The smoke is real, but without addressing its source, it will keep returning.

3. Complex Trauma Survivors

The DSM recognizes post-traumatic stress disorder as a response to an identifiable traumatic event. What it does not adequately recognize, despite decades of clinical and research evidence, is complex trauma. This is the kind of trauma that develops through prolonged exposure to ongoing abuse, violence, or the chronic absence of the safety, attunement, and emotional recognition a developing nervous system requires to form securely.

Complex trauma can result from what happened, such as abuse, violence, neglect, and chronic instability, and equally from what did not happen, including the consistent attunement, emotional mirroring, and relational safety that a child needs and did not reliably receive. Both pathways produce the same result: a nervous system that organized itself around threat, unpredictability, or emotional invisibility, and that carries those early adaptations forward into adult life as chronic dysregulation, relational difficulty, identity fragmentation, and persistent suffering.

This intersection between vulnerability and environment becomes particularly acute when considering Highly Sensitive People. Because an HSP possesses a deeply permeable, finely tuned, and biologically reactive nervous system, their threshold for trauma is structurally different from the general population. For an individual carrying this trait, complex trauma does not require overt physical abuse or catastrophic household dysfunction to take root. It can develop from what the mainstream system routinely classifies as minor emotional traumas, most notably a chronic lack of emotional attunement. When a highly sensitive child grows up with well-meaning but non-attuned caregivers who consistently misread, dismiss, or attempt to over-correct their intense emotional expressions, the child experiences this chronic misattunement as a fundamental threat to relational safety. The nervous system registers this ongoing emotional isolation as a systemic stressor, encoding the survival adaptations of complex trauma underneath the radar of standard clinical metrics.

Complex PTSD was proposed for inclusion in the DSM in the early 1990s by Judith Herman, whose research on the long-term effects of prolonged trauma remains foundational. It was rejected. It did not appear in the DSM-III, DSM-IV, or DSM-5. It was finally included in the World Health Organization's ICD-11 in 2018, twenty-six years after Herman first made the case for its recognition. Because the United States continues to use the DSM, Complex PTSD remains formally unrecognized in the diagnostic system American clinicians are trained to use.

The clinical consequence is that complex trauma survivors are diagnosed with what their symptoms resemble, such as major depression, generalized anxiety, borderline personality disorder, or bipolar disorder. Each of those diagnoses may describe something real, but none of them describes the origin. Treatment aimed at the diagnosis without addressing the developmental wound underneath is management, not healing.

This failure falls disproportionately on communities where trauma is not individual but structural and intergenerational. Racial trauma, meaning the chronic physiological stress of navigating systemic racism, does not remain abstract. It produces measurable nervous system dysregulation that lives in the body across generations. Resmaa Menakem's work demonstrates how racialized trauma is transmitted somatically, how it manifests physically, and why healing it requires approaches that the DSM was not built to recognize or address.

The original ACE study, groundbreaking as it was, did not adequately capture structural and community-level adversity. The adverse childhood experiences of a child growing up in poverty, in an over-policed neighborhood, or in a family carrying intergenerational displacement or loss were not fully measured. The research that shaped how we understand developmental trauma was calibrated to individual households, not to the structural forces that shape them. That gap in the evidence base has clinical consequences that fall heaviest on communities who were already carrying the most.

4. People Who Self-Medicate

The DSM's approach to substance use is organized around the behavior. Criteria for substance use disorder describe patterns of use, consequences of use, and loss of control over use. What the DSM framework does not require a clinician to ask, and does not create space to formally document, is the function the substance serves. What is it doing for this person that nothing else is doing?

For a significant portion of people presenting with substance use disorders, the honest clinical answer is that the substance is performing a regulatory function. It is calming a nervous system that has no other reliable way to calm. It is creating a sense of belonging in a person who has never felt safe enough to belong, or it is numbing a pain that no one has ever helped them process. The substance is not the problem in the primary sense; it is an intelligent, if costly, solution to a problem that predates it.

The DSM cannot see the problem underneath because it was not designed to. Treating the substance use without addressing the wound that made the substance necessary is like mopping the floor while the pipe is still leaking. The floor gets drier for a while, but the leak continues.

This failure has not been distributed equally. The history of addiction treatment in the United States is in part a history of two parallel responses to the same human behavior. Using a substance to manage unbearable pain has been met, in Black and brown communities, with criminalization, resulting in incarceration, criminal records that follow people for decades, the removal of children, and the destruction of families. In white, more affluent communities, the same behavior has been met with treatment facilities, clinical concern, and the language of illness and recovery. This disparity is not historical. It is current, documented, and a direct consequence of whose suffering the system was built to respond to with care.

5. People in Existential Crisis

The DSM contains a category called "Other Conditions That May Be a Focus of Clinical Attention," which includes what it terms a "religious or spiritual problem" alongside other existential concerns. It is, in clinical and reimbursement terms, among the least significant entries in the manual. It carries no diagnostic weight and no billing value. It acts, in effect, as a placeholder that signals the outer boundary of what the system considers treatable.

What falls into that outer boundary is not rare. A significant portion of what presents as major depressive disorder in clinical practice is not, at its root, a biological malfunction. It is a meaning crisis, a life built on premises that no longer hold, or a deep disconnection from the authentic self, from purpose, and from anything that makes the effort of being alive feel worthwhile. The depression is real and the suffering is genuine, but the origin is philosophical and existential rather than neurochemical, and the intervention it requires is not pharmacological.

No medication produces meaning. No antidepressant reconnects a person to their authentic self or resolves the question of whether the life they are living is the life they actually have. The symptom checklist for major depressive disorder cannot distinguish between a person whose low mood reflects a biological vulnerability and a person whose low mood reflects an accurate assessment that their existence has become incoherent. Treating both identically, with the same medication and the same protocol, will help one of them and miss the other entirely.

Beyond Five Populations: The Broader Pattern

The five groups described above are the clearest examples of a structural failure, but they are not the full extent of it.

Anyone whose suffering has a story that matters more than their symptom cluster is at risk of being missed by a system that can only read symptom clusters. Masking, adaptation, meaning loss, and nervous system dysregulation shaped by chronic stress are all human experiences, not clean diagnostic categories. The DSM cannot see a person's developmental history. It cannot see what their nervous system learned in order to survive, nor can it see the gap between who they were required to become and who they actually are. For any patient whose real clinical picture lives in that gap, the diagnosis will be technically correct but clinically insufficient.

The populations described in this essay are missed not through malice but through architecture. A system built to identify and treat biological illness will find biological illness. What it will not find is everything else, and everything else, for a very large number of the people who seek care, is where the actual problem lives.

Thomas Insel, after thirteen years as director of the National Institute of Mental Health and oversight of approximately twenty billion dollars in research, acknowledged that the field had not moved the needle on morbidity and mortality. That is not the record of a system seeing what it needs to see. It is the record of a system looking, with genuine effort and real resources, in the wrong places for a significant portion of the people it is trying to help.

The next essay in this series will examine how adaptation, the intelligent, often unconscious strategies people develop to survive environments that cannot meet their needs, becomes what the system calls mental illness, and why understanding that process is the beginning of a more complete approach to care.

On Diagnostic Reliability and DSM Limitations

• Regier, D. A., Narrow, W. E., Clarke, D. E., et al. (2013). DSM-5 field trials in the United States and Canada, Part II: Test-retest reliability of selected categorical diagnoses. American Journal of Psychiatry, 170(1), 59–70.

• Frances, A. (2013). Saving Normal: An Insider's Revolt Against Out-of-Control Psychiatric Diagnosis, DSM-5, Big Pharma, and the Medicalization of Ordinary Life. William Morrow.

• British Psychological Society. (2018). The Power Threat Meaning Framework. British Psychological Society.

  
  

On High Sensitivity

• Aron, E. N., & Aron, A. (1997). Sensory-processing sensitivity and its relation to introversion and emotionality. Journal of Personality and Social Psychology, 73(2), 345–368.

• Aron, E. N. (1996). The Highly Sensitive Person: How to Thrive When the World Overwhelms You. Broadway Books.

  
  

On Neurodivergence, Masking, and Diagnostic Bias by Race and Gender

• Lai, M. C., Lombardo, M. V., Auyeung, B., Chakrabarti, B., & Baron-Cohen, S. (2015). Sex/gender differences and autism: Setting the scene for future research. Journal of the American Academy of Child and Adolescent Psychiatry, 54(1), 11–24.

• Lockwood Estrin, G., Milner, V., Spain, D., Happé, F., & Colvert, E. (2021). Barriers to autism spectrum disorder diagnosis for adults: A systematic review. Review Journal of Autism and Developmental Disorders, 8(3), 301–316.

• Mandell, D. S., Ittenbach, R. F., Levy, S. E., & Pinto-Martin, J. A. (2007). Disparities in diagnoses received prior to a diagnosis of autism spectrum disorder. Journal of Autism and Developmental Disorders, 37(9), 1795–1802.

  
  

On Complex Trauma and Its Exclusion from the DSM

• Herman, J. L. (1992). Trauma and Recovery: The Aftermath of Violence from Domestic Abuse to Political Terror. Basic Books.

• Maercker, A., Brewin, C. R., Bryant, R. A., et al. (2013). Proposals for mental disorders specifically associated with stress: Cultural and international perspectives. The Lancet, 381(9878), 1683–1685.

• World Health Organization. (2018). International Classification of Diseases, 11th Revision (ICD-11). WHO Press.

• van der Kolk, B. A. (2014). The Body Keeps the Score: Brain, Mind, and Body in the Healing of Trauma. Viking.

  
  

On Adverse Childhood Experiences and Structural Gaps

• Felitti, V. J., Anda, R. F., Nordenberg, D., et al. (1998). Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults: The Adverse Childhood Experiences (ACE) Study. American Journal of Preventive Medicine, 14(4), 245–258.

• Cronholm, P. F., Forke, C. M., Wade, R., et al. (2015). Adverse childhood experiences: Expanding the concept of adversity. American Journal of Preventive Medicine, 49(3), 354–361.

  
  

On Racialized Trauma and the Body

• Menakem, R. (2017). My Grandmother's Hands: Racialized Trauma and the Pathway to Mending Our Hearts and Bodies. Central Recovery Press.

• Williams, D. R., & Mohammed, S. A. (2009). Discrimination and racial disparities in health: Evidence and needed research. Journal of Behavioral Medicine, 32(1), 20–47.

  
  

On Racial Disparities in Diagnosis

• Gara, M. A., Minsky, S., Silverstein, S. M., Miskimen, T., & Strakowski, S. M. (2019). A naturalistic study of racial disparities in diagnoses at an outpatient behavioral health clinic. Psychiatric Services, 70(2), 130–134.

• Schwartz, R. C., & Blankenship, D. M. (2014). Racial disparities in psychotic disorder diagnosis: A review of empirical literature. World Journal of Psychiatry, 4(4), 133–140.

  
  

On Addiction as Adaptation

• Maté, G. (2008). In the Realm of Hungry Ghosts: Close Encounters with Addiction. Knopf Canada.

• Khantzian, E. J. (1997). The self-medication hypothesis of substance use disorders: A reconsideration and recent applications. Harvard Review of Psychiatry, 4(5), 231–244.

  
  

On Existential and Meaning-Based Suffering

• Frankl, V. E. (1959). Man's Search for Meaning. Beacon Press.

• Yalom, I. D. (1980). Existential Psychotherapy. Basic Books.

  
  

On Systemic Outcomes

• Insel, T. (2022). Healing: Our Path from Mental Illness to Mental Health. Penguin Press.